Table 2.
Characteristic | n (%) |
---|---|
Primary Disease | |
Lymphoma | 7 (33.3) |
Leukemia | 7 (33.3) |
Non-Malignant Disease | 7 (33.3) |
Type of Transplant | |
RIC | 12 (57.1) |
Myeloablative | 9 (42.9) |
Stem Cell Source | |
Peripheral Blood | 20 (95.2) |
Cord | 1 (4.8) |
Stem Cell Graft Type (HLA Compatibility) | |
Unrelated Donor | 17 (81.0) |
Related Donor | 4 (19.0) |
Length of Stay [Mean(SD)] | 30.2 (±27.8) |
Note. HSCT, Hematopoietic Stem Cell Transplantation; RIC, Reduced Intensity Conditioning; HLA, Human Leukocyte Antigen.